Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising/recruitment
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All...
  • Videos
  • Collections
    • Recently published
    • Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • About
  • Editors
  • Consulting Editors
  • For authors
  • Transfers
  • Current issue
  • Past issues
  • By specialty
  • Contact
  • Recently published
  • Technical Advances
  • Clinical Medicine
  • Editorials
  • Top read articles
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI Insight
  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement

ResearchIn-Press PreviewImmunologyOncology Free access | 10.1172/jci.insight.132975

Mitochondrial Arginase-2 is a cell autonomous regulator of CD8+ T cell function and anti-tumor efficacy

Adrià-Arnau Martí i Líndez, Isabelle Dunand-Sauthier, Mark Conti, Florian Gobet, Nicolás Núñez, J. Thomas Hannich, Howard Riezman, Geiger Roger, Alessandra Piersigilli, Kerstin Hahn, Sylvain Lemeille, Burkhard Becher, Thibaut De Smedt, Stéphanie Hugues, and Walter Reith

Find articles by Martí i Líndez, A. in: JCI | PubMed | Google Scholar |

Find articles by Dunand-Sauthier, I. in: JCI | PubMed | Google Scholar

Find articles by Conti, M. in: JCI | PubMed | Google Scholar

Find articles by Gobet, F. in: JCI | PubMed | Google Scholar |

Find articles by Núñez, N. in: JCI | PubMed | Google Scholar |

Find articles by Hannich, J. in: JCI | PubMed | Google Scholar |

Find articles by Riezman, H. in: JCI | PubMed | Google Scholar |

Find articles by Roger, G. in: JCI | PubMed | Google Scholar |

Find articles by Piersigilli, A. in: JCI | PubMed | Google Scholar

Find articles by Hahn, K. in: JCI | PubMed | Google Scholar |

Find articles by Lemeille, S. in: JCI | PubMed | Google Scholar

Find articles by Becher, B. in: JCI | PubMed | Google Scholar |

Find articles by De Smedt, T. in: JCI | PubMed | Google Scholar

Find articles by Hugues, S. in: JCI | PubMed | Google Scholar

Find articles by Reith, W. in: JCI | PubMed | Google Scholar

First published November 21, 2019 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.132975.
Copyright © 2019, American Society for Clinical Investigation
First published November 21, 2019 - Version history
Abstract

As sufficient extracellular arginine is crucial for T cell function, depletion of extracellular arginine by elevated Arginase 1 (Arg1) activity has emerged as a hallmark immunosuppressive mechanism. However, the potential cell-autonomous roles of arginases in T cells have remained unexplored. Here we show that the arginase isoform expressed by T cells, the mitochondrial Arginase 2 (Arg2), is a cell-intrinsic regulator of CD8+ T cell activity. Both germ-line Arg2 deletion and adoptive transfer of Arg2-/- CD8+ T cells significantly reduced tumor growth in preclinical cancer models by enhancing CD8+ T cell activation, effector function and persistence. Transcriptomic, proteomic and high-dimensional flow cytometry characterization revealed a CD8+ T cell-intrinsic role of Arg2 in modulating T cell activation, anti-tumor cytoxicity and memory formation, independently of extracellular arginine availability. Furthermore, specific deletion of Arg2 in CD8+ T cells strongly synergized with PD-1 blockade for the control of tumor growth and animal survival. These observations coupled with the finding that pharmacologic arginase inhibition accelerates activation of ex vivo human T cells unveil Arg2 as a new therapeutic target for T cell-based cancer therapies.

Supplemental material

View

Version history
  • Version 1 (November 21, 2019): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Terms of use
  • Standard abbreviations
  • Article usage
  • Citations to this article
  • Share this article
  • Need Help? E-mail the JCI Insight

Go to:

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement
Follow JCI Insight:
Copyright © 2019 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts